World's Best Scientists 2026 revealed!

Jeffrey J. Hale publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Jeffrey J. Hale sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

The last bar groups every scientist with 1,295 publications or more.

Jeffrey J. Hale D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey J. Hale sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

The last bar groups every scientist with 159 D-Index or more.

Overview

Jeffrey J. Hale is affiliated with MSD in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with notable focuses on Infectious Diseases, Immunology, Public Health, Environmental and Occupational Health, Virology, and Molecular Biology.

Their main research topics cover:

  • interferon and immune responses
  • Viral Infections and Vectors
  • Mosquito-borne diseases and control
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Biochemical and Molecular Research

Recent scholarly publications by Hale include:

  • "Nitrofuran-Based STING Inhibitors," published in 2025 in ACS Omega
  • "MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing," published in 2025 in PLoS Biology

Frequent co-authors collaborating with Hale are:

  • Leonard Barasa
  • Leo DeOrsey
  • Maeve O'Reilly
  • Shruti Choudhary
  • Sara Cahill

The primary venues where Hale's work has appeared include:

  • ACS Omega
  • PLoS Biology

Best Publications

  • Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

    Suzanne Mandala;Richard Hajdu;James Bergstrom;Elizabeth Quackenbush

  • Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

    Mark S. Kramer;Neal Cutler;John Feighner;Ram Shrivastava

  • Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

    M. Forrest;S.-Y. Sun;R. Hajdu;J. Bergstrom

  • Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

    J. J. Hale;S. G. Mills;M. Maccoss;P. E. Finke

  • Morpholine and thiomorpholine tachykinin receptor antagonists

    Conrad P. Dorn;Paul E. Finke;Jeffrey J. Hale;Malcolm MacCoss

  • Pyrrolidine modulators of chemokine receptor activity

    Charles Caldwell;Kevin T. Chapman;Jeffrey Hale;Dooseop Kim

  • Selective s1p1/edg1 receptor agonists

    George A. Doherty;Michael J. Forrest;Richard Hajdu;Jeffrey J. Hale

  • Edg receptor agonists

    Robert L. Bugianesi;George A. Doherty;Amy Gentry;Jeffrey J. Hale

  • Pyrrolidine and piperidine modulators of chemokine receptor activity

    Richard J. Budhu;Jeffrey J. Hale;Edward Holson;Christopher Lynch

  • Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties.

    Dooseop Kim;Liping Wang;Jeffrey J. Hale;Christopher L. Lynch

  • The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

    F.D Tattersall;W Rycroft;M Cumberbatch;G Mason

  • (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists

    Vincent J. Colandrea;George A. Doherty;Jeffrey J. Hale;Pei Huo

  • Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P1) Receptor Agonists with Exceptional Selectivity against S1P2 and S1P3

    Zhen Li;Weirong Chen;Jeffrey J Hale;Christopher L Lynch

  • Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720

    Jeffrey J. Hale;William Neway;Sander G. Mills;Richard Hajdu

  • N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists

    George A. Doherty;Zhen Li;Jeffrey J. Hale;Sander G. Mills

  • A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.

    Jeffrey J. Hale;Christopher L. Lynch;William Neway;Sander G. Mills

  • In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

    Nadia M.J. Rupniak;F.David Tattersall;Angela R. Williams;Wayne Rycroft

  • 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists

    Weirong Chen;Jeffrey J. Hale;Zhen Li;Christopher L. Lynch

  • 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists

    Vincent J. Colandrea;George A. Doherty;Jeffrey J. Hale;Christopher Lynch

  • 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists

    George A. Doherty;Jeffrey J. Hale;Irene E. Legiec;Christopher L. Lynch

Frequent Co-Authors

Sander G. Mills
Sander G. Mills MSD (United States)
Malcolm Maccoss
Malcolm Maccoss MSD (United States)
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Hugh Rosen
Hugh Rosen Scripps Research Institute
Kevin T. Chapman
Kevin T. Chapman MSD (United States)
Michael W. Miller
Michael W. Miller MSD (United States)
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Edward M. Scolnick
Edward M. Scolnick Broad Institute
Hong C. Shen
Hong C. Shen Roche (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Chemistry in the USA, exploring related online degrees can broaden career opportunities. Many students look for affordable options, and understanding how much does a criminal justice degree cost offers insight into typical tuition expenses that can be compared across fields.

Additionally, pursuing an online criminal justice associate degree programs highlights the flexibility of online education, which is valuable for Chemistry students balancing lab work and studies. This flexibility also extends to specialized fields like paralegal studies, where different degrees for paralegals offer diverse salary and job prospects.

Moreover, Chemistry graduates often consider careers in pharmaceutical sales. Understanding the pharmaceutical sales rep salary and career paths helps align academic choices with industry expectations, making it easier to plan a successful future.

Best Scientists Citing Jeffrey J. Hale

Trending Scientists

Recently Published Articles